Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001005201-19-000080
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-09 18:26:24
Reporting Period:
2019-05-09
Accepted Time:
2019-05-09 18:26:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1005201 Assertio Therapeutics Inc ASRT Pharmaceutical Preparations (2834) 943229046
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1237262 William Mckee Assertio Therapeutics, Inc.
100 South Saunders Road, Suite 300
Lake Forest IL 60045
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-05-09 12,500 $4.70 67,846 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2019.
  2. The price reported is a weighted average sale price. The shares were sold in multiple same-way transactions on May 9, 2019 at prices ranging from $4.50 to $4.90 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock sold at each separate price.